Medscience

Our Approach

The prospect of commercializing a product across markets in the Middle East and African can be daunting. The idea of establishing a commercial organization and product from scratch in this environment can be often overwhelming, and simply written off. Our value proposition bridges the gap between traditional go-it-alone and out-licensing strategies, by providing a low risk shared-value approach. It could also be called a “go-it-alone – with us” strategy.

  • Flexible Commercialization Models
    For partners aiming to achieve a single market or regional footprint, we build and manage a dedicated go-to-market organization in the major Middle East & African markets.

    For smaller assets that do not justify building a dedicated organization, Medscience manages multiple, non-competing assets in aligned therapeutic areas, passing the synergies on to our partners in the form of improved economic terms.

    Whatever market entry solution best fits their strategy, our partners work closely with a highly experienced and well connected team – from day one of the partnership.
  • Building And Managing Right-Sized Go-to-Market Organizations
    We commercialize our partners’ products on their behalf and in their name. Our partnering models are tailored to fit our partners’ strategic goals and allow them the option to recapture the asset and, if desired, the commercial organization we have built, at any time of the partnership.
  • We Act On Our Partners’ Behalf
    We own our partners’ success, and invest and execute at risk. With Medscience, our partners access the Middle East and Africa markets with a nimble and trusted expert.

    We offer our partners a proven, ready-now team. We know the markets inside out and leverage our unmatched expertise and unparalleled access to KOLs and other key stakeholders for the success of our partners’ products.

    We also have excellent cross-functional expertise to lead the assets through regulatory filing, market access, P&R negotiations, product launch, stakeholder management, and maintenance of long-term value.
  • Unmatched Experience and Expertise
    We have a deep understanding of the Middle East & Africa pharmaceutical markets, which we have gathered in senior executive positions over many years.

    We have mastered the complexities of operating in different jurisdictions, languages, and cultures, and we use our knowledge to maximize the potential for commercial success of our partners’ products regionally and locally.

Pre/Post Biopharmaceuticals Commercialization Services

  • Country prioritization
  • Regulatory filings
  • Organizational development and staffing
  • Supply chain coordination
  • Market access preparations
  • Pricing and reimbursement negotiations
  • Commercial and launch planning
  • Dedicated msls, market access, and key account managers
  • Tender management
  • Management of sub-distributors
Our tailored partnership models for the commercialization of innovative specialty products, are made to fit our partners’ strategic goals.

For partners aiming to achieve a single market or regional footprint, we build and manage a dedicated go-to-market organization in the major Middle East & African markets. As for smaller assets that do not justify building a dedicated organization, we manage multiple, non-competing assets in aligned therapeutic areas, passing the synergies on to our partners in the form of improved economic terms.

Whatever market entry solution best fits their strategy, our partners work closely with a highly experienced and well connected team – from day one of the partnership.

Partner With us

Through targeted investments our distribution expertise, and the commitment of our partners we can develop regional opportunities, making markets more accessible.
Become a Partner